Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials.
- DOI
- 10.1016/j.jgar.2021.10.027
- Published
- 2022 Mar
- Container
- Journal of global antimicrobial resistance
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jgar.2021.10.027,
title = {Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials.},
author = {Dryden M and Kantecki M and Yan JL and Stone GG and Leister-Tebbe H and Wilcox M},
year = {2022},
journal = {Journal of global antimicrobial resistance},
doi = {10.1016/j.jgar.2021.10.027},
url = {https://doi.org/10.1016/j.jgar.2021.10.027}
}RIS
TY - JOUR TI - Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials. AU - Dryden M AU - Kantecki M AU - Yan JL AU - Stone GG AU - Leister-Tebbe H AU - Wilcox M PY - 2022 JO - Journal of global antimicrobial resistance DO - 10.1016/j.jgar.2021.10.027 UR - https://doi.org/10.1016/j.jgar.2021.10.027 ER -
APA
M, D., M, K., JL, Y., GG, S., H, L., & M, W. (2022). Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials.. Journal of global antimicrobial resistance. https://doi.org/10.1016/j.jgar.2021.10.027
Source records
- pubmed · retrieved 2026-09-26T11:10:28.980Z